Iacovino, M. L., Talucci, S., Arenare, L., Caglio, A., Canciello, A., Salerno, F., . . . Perrone, F. (2025). Comparison of baseline patient characteristics in phase 1 and phase 2/3 clinical trials for anticancer treatments. Journal of Translational Medicine, 23(1), 1. https://doi.org/10.1186/s12967-025-06509-z
Chicago Style (17th ed.) CitationIacovino, Maria Lucia, et al. "Comparison of Baseline Patient Characteristics in Phase 1 and Phase 2/3 Clinical Trials for Anticancer Treatments." Journal of Translational Medicine 23, no. 1 (2025): 1. https://doi.org/10.1186/s12967-025-06509-z.
MLA (9th ed.) CitationIacovino, Maria Lucia, et al. "Comparison of Baseline Patient Characteristics in Phase 1 and Phase 2/3 Clinical Trials for Anticancer Treatments." Journal of Translational Medicine, vol. 23, no. 1, 2025, p. 1, https://doi.org/10.1186/s12967-025-06509-z.